Showing results (1221-1230 of 1,307) with videos related to

Sort By:
Pageof 131
Annals of Epidemiology|July 17, 2024
Time trends of the association of body mass index with mortality in 3.5 million young Swedish adultsInnocent B Mboya, Josef Fritz, Marisa da Silva, et al.
Nature Reviews. Neurology|April 12, 2024
Neurofilaments as biomarkers in neurological disorders - towards clinical applicationMichael Khalil, Charlotte E Teunissen, Sylvain Lehmann, et al.
American Journal of Obstetrics and Gynecology|January 9, 2017
Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysisEmily P Barnard, Ahmed M AbdElmagied, Lisa E Vaughan, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2007
Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 geneRichard S Legro, Huiman X Barnhart, William D Schlaff, et al.
Clinical Epigenetics|May 4, 2018
<i>MEST</i> mediates the impact of prenatal bisphenol A exposure on long-term body weight developmentKristin M Junge, Beate Leppert, Susanne Jahreis, et al.
The New England Journal of Medicine|August 7, 2020
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2025
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activitySofia Sandgren, Aleksandra Maleska Maceski, Pascal Benkert, et al.
BMJ Open|July 16, 2024
Cohort profile: The Obesity and Disease Development Sweden (ODDS) study, a pooled cohortMarisa da Silva, Josef Fritz, Innocent B Mboya, et al.
Annals of Neurology|June 10, 2014
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosisLuisa M Villar, Bonaventura Casanova, Nadia Ouamara, et al.
Pageof 131